The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

November 1997

Volume 37, Issue 11

Pages i–ii, 991–1081

  1. Information for Authors

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. INFORMATION FOR AUTHORS (pages i–ii)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04277.x

  2. Therapeutic Review

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. Matrix Metalloproteinases and Coronary Artery Disease: A Novel Therapeutic Target (pages 991–1000)

      Diane C. Celentano and William H. Frishman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04278.x

  3. Erratum

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. You have free access to this content
      ERRATUM (page 1000)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04279.x

  4. Drug Development

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. Optimizing the Absorption of Valspodar, a P-glycoprotein Modulator, Part I: Selecting an Oral Formulation and Exploring its Clinical Pharmacokinetics/Dynamics (pages 1001–1008)

      Dr. E. A. Mueller, Dr. J. M. Kovarik, Dr. Y. Üresin, Dr. S. S. Preisig-Flückiger, Dr. S. Hensel, Dr. P. W. Lücker and Dr B. Holt

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04280.x

  5. Pharmacokinetics

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. The Pharmacokinetics of Tiagabine in Healthy Elderly Volunteers and Elderly Patients with Epilepsy (pages 1015–1020)

      Dr. Sonja Snel, Dr. Jens A. Jansen, Dr. Helle B. Mengel, Dr. Alan Richens and Ms. Soeren Larsen

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04282.x

    2. Single-Dose Pharmacokinetics of Isepamicin in Young and Geriatric Volunteers (pages 1021–1030)

      Dr. Amin A. Nomeir, Elaine Radwanski, Dr. David Cutler, Dr. Melton Affrime, Dr. David Christopher, Chryzanta Korduba, Vijay Batra, Chin-chung Lin and Mitchell N. Cayen

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04283.x

    3. Effect of Repeated Dosing on the Pharmacokinetics of Oral Fluconazole in Bone Marrow Transplant Patients (pages 1031–1037)

      Dr. Adnan El-Yazigi, Dr. Michael Ellis, Dr. Peter Ernst, Ms. Rajaa Hussein and Ms. Fiona J. Baillie

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04284.x

    4. Meta-Analysis of Steady-State Pharmacokinetics of Troglitazone and Its Metabolites (pages 1038–1047)

      Dr. Cho-Ming Loi, Ms. Christine W. Alvey, Dr. Edward J. Randinitis, Dr. Robert Abel, Dr. Malcolm A. Young and Dr. Jeffrey R. Koup

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04285.x

    5. Effect of Glycosylation on Carbamazepine-Serum Protein Binding in Humans (pages 1048–1055)

      Dr. Hikaru Koyama, Dr. Nobuyuki Sugioka, Dr. Akira Uno, Dr. Satoru Mori and Dr. Kenji Nakajima

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04286.x

  6. Drug Interactions

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Erratum
    5. Drug Development
    6. Pharmacokinetics
    7. Drug Interactions
    1. The Effect of Erythromycin on the CYP3A Component of Sertindole Clearance in Healthy Volunteers (pages 1056–1061)

      Dr. Shekman L. Wong, Guoliang Cao, Mr. Randall J. Mack, Mr. Witt and Dr. G. Richard Granneman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04287.x

    2. Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin (pages 1062–1064)

      Dr. Ralph Stern, Dr. Robert Abel, Dr. Gordon L. Gibson and Ms. Judith Besserer

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04288.x

    3. Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers (pages 1065–1072)

      Dr. J. Morganroth, Dr. W. H. Lyness, Dr. J. L. Perhach, Dr. G. G. Mather, Dr. J. E. Harr, Dr. W. F. Trager, Dr. R. H. Levy and Dr. A. Rosenberg

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04289.x

    4. Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and Ethanol (pages 1073–1081)

      Steven M. Troy, Mary Beth Turner, Mary Unruh, Vernon D. Parker and Soong T. Chiang

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04290.x

SEARCH

SEARCH BY CITATION